CureVac's mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage

CureVac said its vaccine can be stored at refrigerator temperatures for up to 3 months. (Guschenkova/iStockGettyImages)

While Pfizer's COVID-19 vaccine turned in strong early efficacy numbers and NIAID Director Anthony Fauci said he expects similar figures from Moderna, the new class of mRNA shots mostly comes with stringent storage requirements that raise logistical hurdles for a broad rollout. Except the program under development at CureVac, which now reports its candidate is stable for up to three months at refrigerator temperatures.

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.